Phase 3 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female and between 18 and 75 years old
- People who are well enough to carry out most daily activities (assessed using a standard medical scale called the Karnofsky Performance Status, with a score of 60 or above)
- People who have been confirmed through laboratory testing to have invasive breast cancer (a specific type called adenocarcinoma)
- People who have had a full mastectomy (removal of the whole breast, with or without preservation of the nipple and surrounding skin area), along with removal or sampling of underarm lymph nodes, and placement of a breast implant or tissue expander — and where the surgery removed all visible cancer with clear margins
- People whose cancer was at a certain stage at the time of surgery: either stage pT3 or with cancer spread to multiple lymph nodes (N2–3), or earlier-stage tumour with limited lymph node involvement (pT1–2N1) (confirm with trial site if unsure which category applies)
- People who have no cancer that has spread to distant parts of the body
- People who have completed their full course of standard chemotherapy given either before or after surgery
- People who are entering the trial within 8 weeks of finishing chemotherapy, or within 12 weeks of surgery if no chemotherapy was given
- People who have read and signed a consent form agreeing to take part in the trial
Who may not be able to join:
- People who have previously had radiation therapy to the chest wall or nearby lymph node areas
- People who are currently pregnant or breastfeeding
- People whose cancer was classified as T4 stage (confirm with trial site)
- People who have had breast reconstruction using their own body tissue (autologous reconstruction) in the breast that would be treated with radiation
- People who have any cancer recurrence — local, regional, or distant — detected before radiation treatment begins
- People who have serious implant-related complications (graded 3 or above on a standard medical scale) that have not resolved before radiation treatment starts
- People who have cancer in both breasts and would require radiation to both sides
- People who have or have had another cancer diagnosed within the last 5 years — except for certain low-risk cancers such as non-melanoma skin cancer, certain thyroid cancers, or a very early form of cervical cancer
- People who have an active connective tissue disease such as lupus or scleroderma
- People who have uncontrolled serious health conditions, including active heart or cardiovascular disease, substance abuse, or unmanaged psychiatric conditions
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-13661135602
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Reconstruction Failure Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.